SIENTRA INC
  SIENTRA INC logo
SIEN

SIENTRA INC (SIEN)

$1.935.85%

Market is closed
– opens on 8 PM, 06 Feb 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.83
Day's Range
$2.07
$1.49
52-Week Range
$33.8
1 month return14.83%
3 month return7.22%
1 year return29.56%
5 year return82.94%

Analyst Recommendation

based on 11 analysts ratings

Buy
81%
Buy
18%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for SIENTRA INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 772.02%

Current

$1.93

Target

$16.83

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
9
8
11
Hold
2
0
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization19.7M
Book Value- $0.69
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)-0.44
PEG Ratio-0.27
Wall Street Target Price16.83

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)13.09
Enterprise Value87.1M
Enterprise Value/Revenue0.99
Enterprise Value/Ebitda-1.67

Technicals

Beta1.59
50 Day MA2.33
200 Day MA6.91

Institutional Holdings

Morgan Stanley - Brokerage Accounts

33.6%

Vanguard Group Inc

27.9%

Blackstone Inc

27.04%

BAMCO Inc

25.53%

Needham Investment Management, LLC

22.97%

Abingworth LLP

16.57%

Company Information

Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company uniquely focused on plastic surgeons. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company's Breast Products Segment includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM®, the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company's miraDry Segment, comprised of its miraDry® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.
Organization SIENTRA INC
Employees319
CEOMr. Ronald Menezes
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is SIENTRA INC share price today?

Can Indians buy SIENTRA INC shares?

How can I buy SIENTRA INC shares from India?

Can Fractional shares of SIENTRA INC be purchased?

What are the documents required to start investing in SIENTRA INC stocks?

What are today’s High and Low prices of SIENTRA INC?

What are today’s traded volumes of SIENTRA INC?

What is today’s market capitalisation of SIENTRA INC?

What is the 52 Week High and Low Range of SIENTRA INC?

How much percentage SIENTRA INC is down from its 52 Week High?

How much percentage SIENTRA INC is up from its 52 Week low?

What are the historical returns of SIENTRA INC?

Who is the Chief Executive Officer (CEO) of SIENTRA INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*